Platform Therapeutics
Andover, US · Founded 2022
The page provides minimal content, with navigation for a pipeline and investors and a tagline about health, suggesting a health or pharmaceutical development company, but no concrete details about its products or activities are stated.
Founders & leadership
JW
JAMES WILKIENamed on SEC filing
LC
LAKHMIR CHAWLANamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.8M disclosed across 1 round · 2026
▶$1.8MraisedAug 2026 · 1 investors · BiotechnologyRule 506(b)
▶$1.8MraisedAug 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- JAMES WILKIEExecutive Officer, Director
- LAKHMIR CHAWLADirector
- Offering amount
- $4M
- Amount sold
- $1.8M
- First sale
- Aug 2026
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Platform Therapeutics do?
- The page provides minimal content, with navigation for a pipeline and investors and a tagline about health, suggesting a health or pharmaceutical development company, but no concrete details about its products or activities are stated.
- How much funding has Platform Therapeutics raised?
- Platform Therapeutics has disclosed $1.8M raised across 1 round.
- Where is Platform Therapeutics headquartered?
- Platform Therapeutics is headquartered in Andover, US.